Manipal further sweetens offer for Fortis Healthcare

NEW DELHI: The Manipal-TPG combine today revised the offer for Fortis Healthcare by committing to invest in the cash-strapped firm at Rs 180 per share, thus increasing the valuation to Rs 9,403 crore.

In a regulatory filing, Fortis Healthcare Ltd (FHL) said it has received revised offer from Manipal and TPG with a proposal to invest in the company, while making public a letter sent by Manipal Health Enterprises Pvt Ltd (MHEPL) to the Fortis board.

Having lost out to the Munjal-Burmans combine last week, Manipal-TPG which was the first to make a offer to Fortis Healthcare Ltd, said that for purposes of the merger, a value of Rs 9,403 crore shall be attributed to FHL under its revised offer.

On the other hand, a value of Rs 6,070 crore shall be attributed to MHEPL as had been originally determined by the independent valuers of for the purpose of the transaction, it said in the letter.

“The preferential allotment shall be undertaken at a price of Rs 180 per share. For purposes of the merger, a value of Rs 9,403 crore shall be attributed to FHL and a value of Rs 6,070 crore shall be attributed to MHEPL as had been originally determined by the independent valuers of for the purpose of the transaction.

  • Related Posts

    CAHO Naa Patients Se Pyaar Hai

    Calcutta:  As Mishty Doi hit it off with over 2000 first rate delegates and healthcare’s quality crusaders from home and abroad, Patient safety resolve took center stage as never before…

    Ameera Shah, Prima Donna of Pathology, makes it to Powerful Healthcare Club NATHEALTH

    New Delhi:  She came, she saw and she conquered- This classic line aptly sums up the meteoric rise and shine of 44 year old Ameera Shah, Promoter &MD of Metropolis…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

    Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

    Organovo’s Drug Significantly Reduces Liver Fat In NASH Study

    Organovo’s Drug Significantly Reduces Liver Fat In NASH Study